Literature DB >> 12667343

[Effects of HLA disparity of two umbilical cord blood units on human engraftment in SCID mice].

Liping Zhang1, Baijun Shen, Huaishui Hou, Wenying Yan, Yunpeng Dai, Qing Shi, Xiufeng Ma, Xiuli Ju, Xingxia Liu.   

Abstract

OBJECTIVE: To evaluate the feasibility and characteristics of human engraftment in HLA disparate cord blood transplantation.
METHODS: Two human HLA-haploidentical or HLA-mismatched cord blood units were transplanted into sublethally irradiated severe combined immunodeficiency (SCID) mice. The characteristics of engraftment, hematopoietic and immunological reconstitution between the two groups were compared.
RESULTS: Two mixed cord blood units can engraft in SCID mice with donor-recipient chimerism and reconstitute hematopoiesis and immunological functions. No unfavorable factors had been observed. Only one of the two cord blood units which had higher colony forming ability in vitro could engraft in most SCID mice as shown by HLA-DQB(1) gene detection. Two HLA-haploidentical cord blood units were simultaneously engrafted in 3 SCID mice.
CONCLUSION: Double HLA-haploidentical or HLA-mismatched cord blood can engraft in SCID mice and reconstitute hematopoietic and immunological functions. HLA disparity has no significant effect on survival and engrafting rate. However, in less HLA disparity group, two cord blood units were prone to engraft simultaneously.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12667343

Source DB:  PubMed          Journal:  Zhonghua Xue Ye Xue Za Zhi        ISSN: 0253-2727


  1 in total

1.  Effect of anti-CD52 antibody alemtuzumab on ex-vivo culture of umbilical cord blood stem cells.

Authors:  Che K Lim; Li Sun; Qi Feng; Ping Law; Wei T Chua; Shy N Lim; William Y K Hwang
Journal:  J Hematol Oncol       Date:  2008-10-23       Impact factor: 17.388

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.